Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
02/2005
02/23/2005CN1585748A NK1 antagonists
02/23/2005CN1585745A Hydroxyfattysulfonic acid analogs
02/23/2005CN1585742A Aryl aniline beta-2 adrenergic receptor agonists
02/23/2005CN1585644A Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
02/23/2005CN1585638A Linked biaryl compounds
02/23/2005CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases
02/23/2005CN1583753A Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics
02/23/2005CN1583139A Preparation of dragon's blood and phospholipin composition
02/23/2005CN1583134A Effervescent tablets of taraxacum mongolicum and their preparation
02/23/2005CN1583130A Frozen dry powder injection of houttuynia cordata and its preparation
02/23/2005CN1583128A Aromatic turmeric oil and its composite vaginal adhered cream and preparation thereof
02/23/2005CN1583120A Capsules for nourshing kidney and strengthening yang and their preparation
02/23/2005CN1583119A Medicine for cold and pain of abdomen before and during menstruation and its preparation
02/23/2005CN1583112A Capsules for nourishing kidney and strengthening yang
02/23/2005CN1583102A Preparation of medicine for blood stasis of woman
02/23/2005CN1583088A Vaginal effervescent tablets for woman inflammation and their preparation
02/23/2005CN1583081A Prescription of
02/23/2005CN1583077A Prescription of
02/23/2005CN1583075A Chinese medicinal prescription for disease of pregnant
02/23/2005CN1583071A Capsules for menopausal syndrome
02/23/2005CN1583063A Extraction of effective components from frankinscene and its preparation and use
02/23/2005CN1583051A Dispersal tablets of thesium Chinese and their preparation
02/23/2005CN1583046A Saponin capsules
02/23/2005CN1583040A Penyanjing capsules and their preparation
02/23/2005CN1583038A Skin bactericidal medicine and its preparation
02/23/2005CN1583012A Chinese medicine for sexual impotence and its production
02/23/2005CN1583003A Pillows for mastosis, e.g., hyperplasia, tumours and other diseases
02/23/2005CN1583002A Bactericidal and disinfecting membrane for birth control
02/23/2005CN1582989A Medicine for hyperplasia of mammary glands and its preparation
02/23/2005CN1582988A Wuzishan Chinese medicines for cancer pains
02/23/2005CN1582978A Medicine for clearing away damp-heat and reducing leukorrhea
02/23/2005CN1582938A Vaginal effervescent tablets of ofloxacin
02/23/2005CN1582936A External used gel of Jiatishacin and its preparation
02/23/2005CN1582924A Skin penetrating paste of indomethacin albuterol
02/23/2005CN1582918A Prescription of soybean isoflavone tablets
02/23/2005CN1582915A Suppository of sodium houttuy fonate
02/23/2005CN1190228C 'Angong' hemostaics
02/23/2005CN1190202C Fat-soluble suppository containing lactobacillus and its preparation method
02/22/2005US6858642 For use in pharmaceutical, skin-protective and cosmetic formulations
02/22/2005US6858629 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same
02/22/2005US6858621 Mbreast and prostate anticancer agents; viricides; alopecia
02/22/2005US6858620 For therapy of male erectile dysfunction; female arousal disorder
02/22/2005US6858615 Phenyl guanidine sodium channel blockers
02/22/2005US6858614 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for treating chronic bronchitis, emphysema, cystic fibrosis, and eye disorders
02/22/2005US6858597 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
02/22/2005US6858594 Compounds and methods for treating urinary incontinence
02/22/2005US6858581 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity
02/17/2005WO2005014816A1 Antigens for immunocontraception
02/17/2005WO2005014613A1 Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereof
02/17/2005WO2005013984A1 Selective serotonin reuptake inhibitors for the treatment of premature female orgasm
02/17/2005WO2005013962A1 Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
02/17/2005WO2004089278A3 Sexual hygienic composition
02/17/2005WO2003070910A3 INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
02/17/2005WO2003025131A3 Protein modification and maintenance molecules
02/17/2005US20050038259 Elastase release inhibitors; such as 19-(1H-tetrazol-5-yl)nonadec-6-en-5-ol
02/17/2005US20050038230 For decreasing food intake; eating disorders; sexual disorders
02/17/2005US20050038072 Nitrogeneous cyclic ketone derivative, process for producing the same, and use
02/17/2005US20050038061 6-Aminomorphinane derivatives, method for production and use thereof
02/17/2005US20050038060 Spiropoperidine compounds as ligands for orl-1 receptor
02/17/2005US20050038044 For drug resistance disease; side effect reduction; antiinflammatory agents; autoimmune disease
02/17/2005US20050038034 Analgesics; neurodegenerative disorders; multiple sclerosis; Parkinson's disease; neuropathic pain
02/17/2005US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
02/17/2005US20050037951 Composition and methods for treatment of sexual dysfunction
02/17/2005US20050037347 Novel cancer-associated genes
02/17/2005US20050037077 Absorption in upper part of gastrointestinal system; microcapsules coated with hydrophilic polymer such as Eudragit
02/17/2005US20050037074 Treating adrenal dysfunction in a patient by administering a pharmaceutically effective amount of a combined glucocorticoid such as hydrocortisone and a delivery vehicle, wherein delivery vehicle provides for delayed and sustained release of glucorticoid; congenital adrenal hyperplasia
02/17/2005US20050037069 Solid and stable creatine/citric acid composition(s) and compositions carbohydrate(s) or hydrates thereof, method for the production and use thereof
02/17/2005US20050037032 Composition and method of treatment for urogenital conditions
02/17/2005US20050037009 Methods and reagents for protease inhibition
02/17/2005US20050037003 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents
02/17/2005US20050036985 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases
02/17/2005US20050035267 Furnace mount and method of installation
02/17/2005US20050035266 Furnace Mount and Method of Installation
02/17/2005CA2534097A1 Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
02/17/2005CA2528904A1 Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereof
02/16/2005EP1506781A1 Vaginal care composition
02/16/2005EP1506285A2 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
02/16/2005EP1506214A1 6-11 bicyclic ketolide derivatives
02/16/2005EP1506205A2 Novel azacyclic ethynyl derivatives
02/16/2005EP1506200A2 Novel diazabicyclic biaryl derivatives
02/16/2005EP1506193A1 Carbamate-substituted pyrazolopyridines
02/16/2005EP1506191A1 Benzoxazine and benzoxazinone substituted triazoles
02/16/2005EP1506185A1 Novel compounds and their use
02/16/2005EP1506178A2 Bicyclic modulators of androgen receptor function
02/16/2005EP1505997A1 Formulations useful in the treatment of male and female impotence
02/16/2005EP1505982A1 Trimegestone and estrogens for treating post menopausal disorders
02/16/2005EP1505980A1 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission
02/16/2005EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
02/16/2005EP1425258A4 Hydroxyeicosenoic acid analogs
02/16/2005EP1421099B1 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents
02/16/2005EP1397365B1 Heteroaryl-diazabicyclo-alkanes as cns-modulators
02/16/2005EP1377584B1 Novel cyclohexenyl phenyl diazepines as vasopressin and oxytocin receptor modulators
02/16/2005EP1281709B1 Novel heterocyclic compounds with anti-inflammatory activity
02/16/2005EP1246814B1 Compounds and methods for modulation of estrogen receptors
02/16/2005EP1244617B1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
02/16/2005EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
02/16/2005CN1582269A Hydroxyeicosenoic acid analogs
02/16/2005CN1582152A composition of estrogen and other hormons with ascorbate, lysine, proline and other substances
02/16/2005CN1582147A Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
02/16/2005CN1582146A Methods of inducing ovulation usig non-polypeptide adenosin phosphate level modulator
1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 557